The Patent Finder

Magainin Pharmaceuticals Inc.

Also on record
Records under this name other than patents Magainin Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Magainin Pharmaceuticals Inc.

PatentTitleStatus Expires Confidence
US 6,261,559Methods of treating asthma with interleukin-9 antibodies
Formerly held
Term ended
Term ended Jun 4, 2019 · From the USPTO record
Term endedTerm ended Jun 4, 2019From the USPTO record
US 6,610,866Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
Formerly held
Term ended
Term ended Mar 22, 2018 · From the USPTO record
Term endedTerm ended Mar 22, 2018From the USPTO record
US 6,262,283Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
Formerly held
Term ended
Term ended Dec 5, 2017 · From the USPTO record
Term endedTerm ended Dec 5, 2017From the USPTO record
US 6,399,370Compositions and methods for use of defensin
Term ended
Term ended Aug 20, 2017 · From the USPTO record
Term endedTerm ended Aug 20, 2017From the USPTO record
US 6,147,060Treatment of carcinomas using squalamine in combination with other anti-cancer agents
Formerly held
Term ended
Term ended Apr 25, 2017 · From the USPTO record
Term endedTerm ended Apr 25, 2017From the USPTO record
US 6,596,712Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
Formerly held
Term ended
Term ended Apr 25, 2017 · From the USPTO record
Term endedTerm ended Apr 25, 2017From the USPTO record
US 6,037,149DNA encoding human asthma associated factor 1
Formerly held
Term ended
Term ended Aug 23, 2016 · From the USPTO record
Term endedTerm ended Aug 23, 2016From the USPTO record
US 6,645,492Methods of treating asthma with interleukin-9 receptor antibodies
Formerly held
Lapsed on the fee record
Ended Nov 11, 2015 · From the USPTO record
Lapsed on the fee recordEnded Nov 11, 2015From the USPTO record
US 6,602,850Method of treating asthma using soluble IL-9 receptor variants
Formerly held
Lapsed on the fee record
Ended Aug 5, 2015 · From the USPTO record
Lapsed on the fee recordEnded Aug 5, 2015From the USPTO record
US 6,962,909Treatment of neovascularization disorders with squalimine
Formerly held
Term ended
Term ended Jun 22, 2015 · From the USPTO record
Term endedTerm ended Jun 22, 2015From the USPTO record
10 of 47 patents shown.
Pro members see all 47.
Pro members: see all 47 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited